Detalhe da pesquisa
1.
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
BMC Med
; 21(1): 87, 2023 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882736
2.
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.
Ther Adv Med Oncol
; 13: 1758835920987657, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33613700
3.
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME).
BMJ Open
; 9(2): e023568, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30796119
4.
Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national study.
Eur J Cancer
; 118: 131-141, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330488
5.
Retrieving the Vital Status of Patients with Cancer Using Online Obituaries.
Stud Health Technol Inform
; 247: 571-575, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29678025
6.
Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
J Nucl Med
; 56(3): 339-46, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25678490
7.
Reference ranges for serum S100B protein during the first three years of life.
Clin Biochem
; 44(10-11): 927-9, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21601568